About 100 reports

  • SEASONAL INFLUENZA & VACCINATION
  • 5.10 NETHERLANDS - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • GLOBAL LIVE ATTENUATED INFLUENZA VACCINES MARKET
  • Market definition

GLOBAL RECOMBINANT INFLUENZA VACCINES MARKET Currently, only one recombinant influenza vaccine, Flublok, is approved by the US Food and Drug Administration (FDA) for influenza.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • Seasonal Influenza Key Facts
  • Seasonal Influenza Development Pipeline, by Phase

Seasonal Influenza: Competitive Landscape to 2026 Report Code: GDHC##CL Published: November 2018 Healthcare TABLE OF CONTENTS ##.

  • Influenza
  • United States
  • Roche Group
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • RIDTS FOR INFLUENZA A
  • RIDTS FOR INFLUENZA B

You can easily book an appointment with one online.

  • Influenza
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation
  • Types of human influenza viruses
  • Global influenza diagnostics market by geography 2016-2021

Global Influenza Diagnostics Market: About this market Influenza diagnostic kits are available in both rapid and conventional testing models.

  • Diagnostics
  • Influenza
  • World
  • Forecast

Influenza Market, by Segment, Through 2022 Table ## : European Influenza Market, by Segment, Through 2022 Table ## : Approved WHO Influenza Centers, by Region Table ## : Abbreviations Used in Influenza Markets Table ## : Glossary of Terms Used in

  • Influenza
  • Therapy
  • Vaccine
  • World
  • COLD AND FLU DRUGS
  • IV.COLD AND FLU DRUGS PRODUCTION AND DEMAND

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • COLD AND FLU DRUGS
  • Cold and Flu Drugs Companies in China

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • 5.15 AUSTRALIA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 5.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • COLD AND FLU DRUGS EXPORT (BILLION YUAN)
  • Cold and Flu Drugs Sales Volume by Price

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Cold and Flu Drugs in China is growing rapidly.

  • Influenza
  • China
  • Demand
  • Sanshine Pharmaceutical Co., Ltd.
  • Shineway Pharmaceutical Co., Ltd.

& nbsp; Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Tuberculosis
  • Europe
  • World
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Medical Biotechnology
  • Europe
  • World
  • Demand
  • Influenza Vaccines
  • Influenza Drugs

(c) AZOTH Analytics ##.

  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • INFLUENZA SYMPTOMS
  • SEASONAL INFLUENZA VACCINES MARKET

PLOS ONE; ##(##): E##.

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation

Influenza Diagnostic Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Demand

Influenza Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Market Size
  • 1.1 INFLUENZA
  • TYPES OF INFLUENZA

Pain when one moves eyes.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • 5. Influenza Vaccines Brand Sales and Forecast
  • 7. Influenza Vaccines Market - Driving Factors

Mexico ##.

  • Influenza
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • 5. Influenza Vaccines Brand Sales and Forecast
  • 7. Influenza Vaccines Market - Driving Factors

The vaccination coverage rate is given below: FORECAST 2011 - ## 2012 - ##. ## 2013 - ##. ## 2014 - ##. ## 2015 - ##. ## 2016 - ##. ## FIGURE ##-##: GERMANY - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES (MILLION), 2011 - 2015 2017 - ##. ## 2018 - ##. ## 2019 - ##. ## 2020 - ##. ## 2021 - ##. ##

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • Previous Flu Seasons in the United States
  • Americans' attitudes towards the flu vaccination

An estimated one third of American workers get no paid time off when they are sick, so cannot afford to take time off.

  • Influenza
  • Vaccine
  • United States
  • Demand
  • Mondelez International, Inc.

Seasonal Influenza Vaccines CONTENTS ## FORECAST: SEASONAL INFLUENZA VACCINES (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET OVERVIEW AND TRENDS ## KEY DRIVERS AND RESISTORS OF CONVERSION TO QIVS ## MARKET DEFINITION AND METHODOLOGY ## US MARKET

  • Influenza
  • Pathology
  • Vaccine
  • European Union
  • United States
  • Seasonal Influenza Vaccine Market
  • 2. Influenza - Introduction

Table ##-##: Notable Influenza Pandemics ##.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • 4.10 AUSTRALIA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 4.2 CHINA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND

FORECAST FIGURE ##-##: HONG KONG - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES (MILLION), 2011 - 2015 FIGURE ##-##: HONG KONG - FORECAST FOR NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES (MILLION), 2016 - 2021 Source: iGATE Research Analysis ##. ## ## ##. ## ##

  • Influenza
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Compet

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Compet

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – US Overview An interview with a US key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential for a univer

  • Influenza
  • Therapy
  • Vaccine
  • United States
  • Social Conditions

Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interview – UK Overview An interview with a UK key opinion leader (KOL) on seasonal influenza vaccination coverage rates and trends in main risk groups, key marketed vaccines, pipeline approaches, and the potential for a univer

  • Influenza
  • Therapy
  • Vaccine
  • United Kingdom
  • Social Conditions

The Influenza A Virus, H##N## Subtype Infections pipeline guide presents information on all active drugs currently being developed for Influenza A Virus, H##N## Subtype Infections.

  • Influenza
  • Pathology

The Influenza A Virus H##N## Subtype Infections pipeline guide presents information on all active drugs currently being developed for Influenza A Virus H##N## Subtype Infections.

  • Drug Development
  • Influenza

The Influenza B virus Infections pipeline guide presents information on all active drugs currently being developed for Influenza B virus Infections.

  • Drug Development
  • Influenza